676 North Saint Clair, Suite 1200 Chicago, Illinois 60611 VISIT OUR WEBSITE lynnsagebreastcancer.org 19TH ANNUAL LYNN SAGE BREAST CANCER SYMPOSIUM SEPTEMBER 14-17, 2017 Chicago Marriott Downtown Magnificent Mile SYMPOSIUM CHAIR William Gradishar, MD SYMPOSIUM CO-CHAIRS Monica Morrow, MD V. Craig Jordan, OBE, PhD, DSc Nora Hansen, MD Referred to as the most valuable breast cancer meeting worldwide for the practicing clinician, the Lynn Sage Breast Cancer Symposium provides 3.5 days of formal presentations and interactive case discussions. For 19 years, this multidisciplinary CME program has been bringing together leading national and international medical, surgical, and radiation oncologists to present, debate, and evaluate cutting-edge technology and approaches in the management of breast cancer. Progress across all aspects of patient care, including prevention, screening, detection, and survivorship, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, and novel biologic therapies are leading to new strategies and therapeutic options. The symposium focuses on the close cooperation required for effective multidisciplinary management of patients with breast cancer. Educational Objectives At the conclusion of this activity, participants will be able to: » Practice current management approaches to high-risk benign breast lesions. » Describe factors influencing the choice of initial therapeutic approaches— neoadjuvant chemotherapy, mastectomy or oncoplastic breast conservation in operable breast cancer. » Identify the multidisciplinary challenges and opportunities associated with the use of neoadjuvant chemotherapy in operable breast cancer. » Apply optimal pain management strategies in patients with breast cancer. » Employ optimal strategies for overcoming endocrine resistance by incorporating targeted therapies. » Cite the clinical and molecular factors that determine the optimal duration of adjuvant endocrine therapy. » Utilize optimal surgical and medical interventions in the elderly with breast cancer. PROGRAM DESCRIPTION CONFIRMED FACULTY Benjamin Anderson, MD University of Washington Jose Baselga, MD, PhD Memorial Sloan Kettering Cancer Center Richard Bleicher, MD Fox Chase Cancer Center Thomas Buccholz, MD The University of Texas MD Anderson Cancer Center Harold Burstein, MD, PhD Harvard Medical School Massimo Cristofanilli, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University Sarah Friedewald, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University William Gradishar, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University Nora Hansen, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University Kevin Hughes, MD Massachusetts General Hospital Arti Hurria, MD City of Hope Reshma Jagsi, MD, PhD University of Michigan V. Craig Jordan, OBE, PhD, DSc The University of Texas MD Anderson Cancer Center Malcolm Kell, MD Mater Misericordiae University Hospital Seema Khan, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University John Kim, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University Tari King, MD Dana-Farber Cancer Institute of Harvard Medical School Jennifer Ligibel, MD Harvard University Elizabeth Mittendorf, MD, PhD The University of Texas MD Anderson Cancer Center Monica Morrow, MD Memorial Sloan Kettering Cancer Center Hyman Muss, MD University of North Carolina Lineberger Comprehensive Cancer Center Ruth O’Regan, MD University of Wisconsin Carbone Cancer Center Joyce O’Shaughnessy, MD Texas Oncology & US Oncology/ Baylor Sammans Cancer Center Judith Paice, PhD, RN Robert H. Lurie Comprehensive Cancer Center of Northwestern University Lajos Pusztai, MD Yale University Abram Recht, MD Beth Israel Deaconess Medical Center/ Harvard Medical School Mark Robson, MD Memorial Sloan Kettering Cancer Center Stuart Schnitt, MD Beth Israel Deaconess Medical Center/ Harvard Medical School Andrew Seidman, MD Memorial Sloan Kettering Cancer Center Kalliopi Siziopikou, MD, PhD Robert H. Lurie Comprehensive Cancer Center of Northwestern University Dennis Sgroi, MD Massachusetts General Hospital Lawrence Solin, MD Albert Einstein Healthcare Network Fraser Symmans, MD The University of Texas MD Anderson Cancer Center Melinda Telli, MD Stanford University Julia Trosman, PhD, MBA Robert H. Lurie Comprehensive Cancer Center of Northwestern University Gary Ulaner, MD Memorial Sloan Kettering Cancer Center Conference Location and Accommodations The Chicago Marriott Downtown Magnificent Mile is conveniently located in the heart of downtown Chicago at 540 N. Michigan Avenue. A limited number of guest rooms have been held for Symposium attendees at the discounted rate of $277 plus tax per night through August 23, 2017. Contact the hotel directly at 312.836.0100 or use the link on our website. Mention the Lynn Sage Breast Cancer Symposium for the reduced rate. Special Assistance In compliance with the Americans with Disabilities Act, Northwestern University will make all reasonable efforts to accommodate persons with disabilities at this meeting. Additionally, if you have any special dietary restrictions, please notify our office at 312.695.1392 prior to the conference. Accreditation Statement The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 21.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Credits The American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credits(s)™ from organizations accredited by the ACCME. For additional information or to register visit lynnsagebreastcancer.org or call 312.695.1392. Register by July 31, 2017 for early bird discount Faculty Disclosure Current guidelines state that participants in CME activities should be made aware of any affiliation of financial interest that may affect the speaker’s presentation. Each speaker has been requested to complete a faculty disclosure form. The names of faculty members declaring a relationship or who will be discussing off–label usage will be indicated in the course syllabus.